1. Sweden Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
New Nordic Healthbrands AB

New Nordic Healthbrands AB

SSTO:NNH
17.50
SEK
-0.50
(-2.78%)
1.39EPS
8.71P/E
74.96MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
36.8
43.9
48.18
49.37
55.65
63.55
73.06
72.65
83.1
78.69
86.17
88.83
93.03
95.2
Basic EPS, GAAP
0.93
2
1.83
1.55
3.28
4.28
4.53
2.87
3.44
-0.46
-1
-1.24
1.32
1.39
Free Cash Flow per Basic Share
- -
0.42
-0.54
-1.59
4.23
2.74
-0.38
2.87
-1.7
-2.97
4.03
-1.59
0.79
0.47
Dividend per Share
- -
- -
- -
0.25
0.4
1.15
1.5
1.75
1.5
1.25
- -
- -
- -
- -
Book Value per Share
2.19
4.04
5.77
6.94
9.82
12.95
16.45
16.92
19.42
18.17
17.11
16.29
16.7
17.54
Tangible Book Value per Share
1.34
3.56
5.66
6.9
9.81
12.95
16.33
16.64
18.93
17.59
16.54
15.42
15.62
16.43
Basic Weighted Avg Shares
6
6
6
6
6
6
6
6
6
6
6
6
6
6
Sales/Revenue/Turnover
228
272
298
306
345
394
453
450
515
488
534
550
576
590
Operating Margin (%)
4.02
5.96
5.27
4.25
8.02
8.69
8.02
5.3
5.55
-0.97
-0.59
-0.81
2.63
2.54
Depreciation Expense
3
3
3
1
1
1
1
1
1
2
2
3
2
3
Net Income, GAAP
6
12
11
10
20
27
28
18
21
-3
-6
-8
8
9
Effective Tax Rate (%)
26.77
25.11
20.44
23.55
25.14
22.26
22.16
23.73
23.8
- -
- -
- -
34.5
35.28
Profit Margin (%)
2.54
4.55
3.8
3.13
5.89
6.74
6.2
3.95
4.14
-0.58
-1.16
-1.4
1.42
1.46
Working Capital
2
14
31
39
59
78
99
103
114
100
90
80
84
90
LT Debt
1
1
1
1
1
1
2
- -
- -
- -
- -
2
2
2
Total Equity
14
25
36
43
61
80
102
105
120
113
106
101
103
109
Return on Invested Capital (%)
29.72
39.35
26.37
14.95
28.25
33.56
27.33
15.93
16.91
- -
- -
- -
7
6.75
Return on Capital (%)
36.42
45.94
26.97
15.88
29.08
34.91
28.69
16.52
17.33
- -
- -
- -
6.86
6.87
Return on Common Equity (%)
52.5
64.11
37.25
24.31
39.11
37.62
30.83
17.19
18.93
-2.42
-5.67
-7.44
8.02
8.26

Capital Structure

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
34
37
35
LT Borrowings
2
2
2
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
6
Market Capitalization
144
106
75

Working Capital

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
224
242
272
Cash, Cash Equivalents & STI
17
9
10
Accounts Receivable, Net
91
102
122
Inventories
104
116
122
Total Current Liabilities
140
160
181
Payables & Accruals
- -
- -
- -
ST Debt
34
37
35
Deferred Revenue
- -
- -
- -

Growth Rates

SEK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.37%
0.05%
2.53%
Free Cash Flow
-178.79%
-121.87%
-149.99%
Net Income, GAAP
-5.98%
-31.21%
-206.44%
Sales/Revenue/Turnover
7.02%
5.28%
4.73%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
130
141
130
150
550
2025
144
143
- -
151
576
2026
132
164
- -
- -
- -

Quarterly Earnings Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.55
-0.72
-0.28
0.31
-1.24
2025
0.43
0.34
- -
0.33
1.32
2026
-0.46
1.18
- -
- -
- -

Quarterly Dividends Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Karl Kristian Bergman Jensen
Full Time Employees
78
Sector
Health technology
Industry
Pharmaceuticals: other
Address
Hyllie Boulevard 34 Malmö SN Sweden 215 32
IPO Date
Jan 23, 2007
Website
newnordic.se
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
New Nordic Healthbrands AB (publ) (NNH.ST) develops, markets, and sells dietary supplements, herbal pharmaceuticals, natural medicines, and personal care products targeting specific health and beauty concerns including diet, vitality, sleep, anti-ageing, hair, skin, nails, immune support, vision, and liver health; core brands and product lines encompass Apple Cider, BioFirm, Chili Burn, Blue Berry, Frutin, Active Liver, dida, Hair Volume, Nail Strong, and Skin Care. Products utilize natural ingredients such as herbal extracts, vitamins, micronutrients, and fatty acids, sold through retailers in over 44 countries with primary operations in the Nordic region, rest of Europe including strong growth in England, Ireland, and Germany, and other international markets. Founded in 1990 and headquartered in Malmö, Sweden at Hyllie Boulevard 34, the company lists on Nasdaq First North Growth Market Sweden since 2007 and employs approximately 73 people. Recent developments include reporting revenue growth of 10% in Q1 2025 continuing positive Q4 2024 momentum with successful new product launches and enhanced retail collaborations particularly in England and Ireland; issuance of the 2024 full year and annual reports alongside six-month and nine-month 2024 reports reflecting directional improvement; communication from the 2025 annual general meeting and nomination committee proposals for the board; and launch of new brand Kunkeei Beauty Liquid as part of ongoing innovation.